Primary care clinicians key to achieving optimal cardiovascular health
Primary care clinicians and practices are uniquely positioned to help people achieve optimal cardiovascular health through screening, diagnosing and treating ...
Tag: Weight Loss
Study reveals liver-brain communication as key to managing circadian eating patterns and obesity
Research highlights the hepatic vagal nerve’s role in regulating food intake rhythms, offering new insights for potential anti-obesity treatments. Study: Hepatic ...
Weight loss drug semaglutide may offer relief for knee arthritis pain
New research highlights the potential for weight-loss medication to ease arthritis symptoms, offering hope for improved mobility and pain relief. ...
Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity
The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. ...
Semaglutide improves heart health and reduces weight in obese patients, but with side effects
Study shows that semaglutide not only aids in weight loss but also slashes heart failure risk by 76% in overweight ...
Semaglutide cuts death rates from cardiovascular disease and COVID-19
Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, ...
Clarification urgently needed for detected signal of semaglutide-linked suicidal ideation
Study: Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality. Image Credit: myskin / Shutterstock.com In a recent ...
Study highlights benefits of exercise for both men and women
Females' and males' muscles differ in glucose and fatty acid handling – but regular physical activity quickly triggers similar beneficial ...
Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management
In a recent review published in the journal Frontiers Endocrinology, researchers collate and elucidate recent clinical and pathophysiological knowledge on ...
Study suggests gastric bypass can reduce cardiovascular disease risk, irrespective of weight loss
In a recent study published in JAMA Surgery, researchers investigated whether Roux-en-Y gastric bypass (RYGB) reduces cardiovascular risk factors independent ...
